Post-approval studies (Phase 4)Study completedNCT00405418What this trial is testingLantus Versus Levemir Treat-To-TargetWho this might be right forDiabetes Mellitus, Type 2 Sanofi 973
Post-approval studies (Phase 4)Study completedNCT00118963What this trial is testingEffect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-DiabetesWho this might be right forDiabetes Mellitus, Type 2 Steno Diabetes Center Copenhagen 102
Large-scale testing (Phase 3)Study completedNCT00434954What this trial is testingEffect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus AstraZeneca 494
Not applicableStudy completedNCT00806936What this trial is testingObservational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes SubjectsWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 4,847
Post-approval studies (Phase 4)Looking for participantsNCT06671587What this trial is testingIGlarLixi CGM Study in Chinese T2D Individuals After OADsWho this might be right forType 2 Diabetes (T2D) Sanofi 678
Post-approval studies (Phase 4)Study completedNCT01232491What this trial is testingImpact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 611
Large-scale testing (Phase 3)Study completedNCT02268214What this trial is testingDapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesWho this might be right forType 1 Diabetes Mellitus AstraZeneca 833
Post-approval studies (Phase 4)Study completedNCT01471808What this trial is testingEffects of Different Early Intensive Therapies on Long-term β-cell FunctionWho this might be right forDiabetes Mellitus, Type 2 Sun Yat-sen University 264
Large-scale testing (Phase 3)Study completedNCT01499095What this trial is testingComparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyWho this might be right forType 2 Diabetes Mellitus Sanofi 811
Post-approval studies (Phase 4)Study completedNCT01698931What this trial is testingEfficacy of Repaglinide in Subjects With Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 9
Not applicableStudy completedNCT01492166What this trial is testingObservational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical PracticeWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 1,935
Post-approval studies (Phase 4)Study completedNCT00036504What this trial is testingEfficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without InsulinWho this might be right forType 2 Diabetes Mellitus Eli Lilly and Company 100
Large-scale testing (Phase 3)Study completedNCT03798080What this trial is testingComparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal InsulinWho this might be right forType 2 Diabetes Mellitus Sanofi 426
Not applicableStudy completedNCT00563004What this trial is testingThe Effect of DBcare, a Food Supplement on Diabetes ControlWho this might be right forDiabetes Mellitus, Non-insulin DependantDiabetes Mellitus Type 2Diabetes Mellitus, on Oral Hypoglycemic Treatment+1 more Meir Medical Center 35
Large-scale testing (Phase 3)Study completedNCT02460978What this trial is testingDapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesWho this might be right forType 1 Diabetes Mellitus AstraZeneca 815
Testing effectiveness (Phase 2)Study completedNCT00850096What this trial is testingEffects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes CPEX Pharmaceuticals Inc. 94
Large-scale testing (Phase 3)Ended earlyNCT03434119What this trial is testingEfficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic AgentsWho this might be right forType 2 Diabetes Mellitus Sanofi 241
Post-approval studies (Phase 4)Study completedNCT02954692What this trial is testingEvaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in TurkeyWho this might be right forType 2 Diabetes Mellitus Sanofi 112
Not applicableStudy completedNCT00700960What this trial is testingObservational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 2,745
Large-scale testing (Phase 3)Study completedNCT02752412What this trial is testingEfficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic DrugsWho this might be right forType 2 Diabetes Mellitus Sanofi 513